When was NRx Pharmaceuticals, Inc. stock made available for the first time to the public?

The IPO Date for NRx Pharmaceuticals, Inc. is 2017-12-01. On this 2017-12-01, NRx Pharmaceuticals, Inc. stock was made publicly available.

Where is the headquarters of NRx Pharmaceuticals, Inc. stock?

Headquarters of NRx Pharmaceuticals, Inc. is in US at 1201 Orange Street, Wilmington, DE 19801.

What industry does NRx Pharmaceuticals, Inc. belong to?

The NRx Pharmaceuticals, Inc. belongs to Biotechnology.

NRx Pharmaceuticals, Inc.

NRXPW•NASDAQ

Healthcare

Biotechnology

$0.09

$-0.01(-8.07%)

NRx Pharmaceuticals, Inc. (NRXPW) Company Profile & Overview

Explore NRx Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

NRx Pharmaceuticals, Inc. (NRXPW) Company Profile & Overview

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.

SectorHealthcare

IndustryBiotechnology

CEOJonathan C. Javitt

Contact Information

https://www.nrxpharma.com

484 254 6134

1201 Orange Street, Wilmington, DE, 19801

Company Facts

IPO DateDec 1, 2017

CountryUS

Actively Trading

Frequently Asked Questions

;